跳至主要内容
临床试验/CTRI/2018/07/014952
CTRI/2018/07/014952尚未招募4 期

Effectiveness of Tranexamic acid in the treatment of Melasma - A randomized controlled clinical trial.

Hindu Mission Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients with diagnosis of melasma .
  • 2.Age 18 - 55 years, of either gender.
  • 3.Absence of other confounding inflammatory dermatoses (eg. Exogenous ochronosis, Acanthosis nigricans, post inflammatory hyperpigmentation, Pigmented cosmetic dermatitis, Actinic lichen planus, malar rash, etc.)
  • 4.Willing to follow the study procedures and give written informed consent.

排除标准

  • 1.Pregnancy and lactation.
  • 2.Any chronic medical illness,
  • 3.History of thrombosis, abnormal bleeding profile,
  • 4.Any medical treatment for melasma within 1 month of entry,
  • 5.Skin resurfacing by dermabrasion, chemical peels, and facial laser within the preceding 9 months,
  • 6.Hypersensitivity to TXA,
  • 7.Abnormal bleeding time, clotting time or platelet count

研究者

相似试验